Related references
Note: Only part of the references are listed.Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Emerging agents that target signaling pathways in cancer stem cells
Yue Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
Yena Cho et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher et al.
FRONTIERS IN IMMUNOLOGY (2020)
Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
Kousik Kesh et al.
CANCERS (2020)
Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells
Abdul Q. Khan et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells
Sau Har Lee et al.
STEM CELL REVIEWS AND REPORTS (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
Katharina Rothe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical and Therapeutic Implications of Cancer Stem Cells
Michael F. Clarke
NEW ENGLAND JOURNAL OF MEDICINE (2019)
FMS-LIKE TYROSINE KINASE 3/FLT3: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Julhash U. Kazi et al.
PHYSIOLOGICAL REVIEWS (2019)
The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies
Larisa Ryskalin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin et al.
CELL STEM CELL (2019)
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Lan Thi Hanh Phi et al.
STEM CELLS INTERNATIONAL (2018)
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
A. Po et al.
ONCOGENE (2017)
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Kiyoung Eun et al.
BMB REPORTS (2017)
Cancer stem cells and chemoresistance: The smartest survives the raid
Jihe Zhao
PHARMACOLOGY & THERAPEUTICS (2016)
Wnt Signaling in Cancer Stem Cell Biology
Felipe de Sousa e Melo et al.
CANCERS (2016)
SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets
Shigekazu Murakami et al.
STEM CELLS (2015)
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Robert J. Vanner et al.
CANCER CELL (2014)
Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
Steven M. Chan et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)
Nuzhat N. Kabir et al.
MEDICAL ONCOLOGY (2013)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
Max Jan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Oct4 is Expressed in Human Gliomas and Promotes Colony Formation in Glioma Cells
Zhanhui Du et al.
GLIA (2009)
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model
Li Li et al.
BLOOD (2008)
Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors
Omobolaji O. Akala et al.
NATURE (2008)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
